Market Size
The Global Bone Growth Stimulators Market reached US$ 1.81 billion in 2025 and is expected to reach US$ 2.70 billion by 2033, growing at a CAGR of 5.1% during the forecast period 2026-2033.
Bone growth stimulators improve the body's bone healing process in patients undergoing bone fusion surgery. These stimulators can be worn outside or used during implantation therapies such as cardiac resynchronization therapy(CRT), & implantable cardioverter defibrillators (ICD). It can heal bone fractures by applying electrical or ultrasound waves. This non-invasive bone healing treatment method is an alternative to bone grafts.
The growth of this market is driven by the increasing preference for minimally invasive treatments, rising cases of bone fractures and spinal injuries, increasing geriatric population and subsequent increase in the cases of orthopedic disease and injuries, and growing incidences of sports injuries.
In addition, the growing number of hospitals and surgical centers worldwide, increasing utilization of platelet and rich plasma (PRP) in other applications, and emerging economies offer opportunities for the growth of this market.
Market Scope
| Metrics | Details |
| CAGR | 5.1% |
| Market Size | 2023-2033 |
| Market Estimation Forecast Period | 2026-2033 |
| Revenue Units | Value (US$ Mn) |
| Segments Covered | Product, Application, and End-User |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Launches, Growth Strategies, Revenue Analysis, Porter's Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights. |
For more details on this report - Request for Sample
Market Dynamics: Drivers
Growing Demand for the Non-Invasive and Minimally Invasive Surgeries Treatments
The demand for the global bone growth stimulators market is driven by multiple factors. One of the key factors is that patients are increasingly opting for non-invasive and minimally invasive surgical treatments due to their benefits over traditional procedures, such as fewer complications, shorter hospitalization, reduced pain, lower risk of infections, and faster recovery.
Moreover, major players in the industry introduced innovative platforms and technologies that would propel this market growth. For instance, in May 2023, Orthofix Medical Inc., a prominent company specializing in spine and orthopedic solutions, declared that its STIM onTrack mobile app received an award for the "Best Patient Engagement Mobile App" from MedTech Breakthrough.
Also, in April 2023, Orthofix Medical, an eminent company in the spine and orthopedics sector, introduced two access retractor systems tailored for minimally invasive spine (MIS) procedures. The launch of the Lattus lateral access system and the Fathom pedicle-based retractor system upgrades the company's portfolio of access solutions.
Restraints
Factors such as product recalls, high cost of treatment and diagnosis, stringent approval process, limited medical reimbursement policies, adverse effects of BMP-based therapy, and limited awareness among people are expected to hamper the market.
Segment Analysis
The global bone growth stimulators market is segmented based on product, application, end-user, and region.
The spinal fusion surgeries segment accounted for approximately 55.8% of the global bone growth stimulators market share
The spinal fusion surgeries segment is expected to hold the largest market share over the forecast period. An electrical bone growth stimulator is a supplemental form of therapy for spinal fusion surgery. It may be used as an adjunct to spinal fusion surgery to help enhance the chances of achieving a successful bone fusion.
Furthermore, major key players in the industry introduce people awareness publications and device approvals help to drive this market growth. For instance, in December 2023, Orthofix Medical Inc. announced the publication of new data from a prospective, multicenter study investigating Pulsed Electromagnetic Field (PEMF) stimulation as an adjunct therapy to lumbar spinal fusion procedures in patients at risk for pseudarthrosis.
For the same source, the SpinalStim device is the only bone growth stimulation therapy system that is FDA-approved as both an adjunct treatment for lumbar spinal fusion and as a nonsurgical treatment for spinal pseudarthrosis.
Similarly, in April 2024, the Xstim received premarket approval from the US Food and Drug Administration (FDA) for its Xstim spine fusion stimulator. Xstim's spinal fusion device is a wearable non-invasive bone growth stimulation device that emits a low-energy signal that promotes bone healing in patients following spinal fusion surgery.
Market Segmentation
By Product
- Implanted Bone Growth Stimulators
- Ultrasonic Bone Growth Stimulators
- External Bone Growth Stimulators (Combined Magnetic Field (CMF) Devices
- Pulsed Electromagnetic Field (PEMF) Devices
- Capacitive Coupling (CC) Devices)
- Non-Invasive Bone Growth Stimulators
- Invasive Bone Growth Stimulators
- Others
By Application
- Spinal Fusion Surgeries
- Trauma Injury and Fractures
- Osteogenesis
- Oral and Maxillofacial Surgeries
- Delayed Union & Nonunion Bone Fractures
- Others
By End-Users
- Orthopedic Clinics
- Hospitals
- Ambulatory Surgical Centers
- Academic & Research Institutes
- Home Care
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
- South America
- Brazil
- Argentina
- Rest of South America
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
Competitive Landscape
The major global players in the bone growth stimulators market include Zimmer Biomet, Orthofix Medical Inc., Enovis Corporation, ZimVie Inc., OssaTechnics, Kinex Medical Company, LLC, VQ OrthoCare, SIG Orthopaedic, Elizur, and IGEA S.p.A. among others.
Key Developments
February 2026: Orthofix Medical Inc. expanded its bone growth therapies business across North America through strong sales growth in non-invasive bone stimulation devices and continued investments in spinal fusion recovery technologies.
January 2026: Medtronic Plc strengthened its orthopedic and spine care portfolio across the United States and Europe by increasing adoption of advanced bone morphogenetic protein technologies and minimally invasive bone healing solutions.
December 2025: Rising demand for portable and home-based bone growth stimulators across Asia-Pacific accelerated development of patient-centric electromagnetic and ultrasound bone healing devices by leading orthopedic manufacturers.
November 2025: Zimmer Biomet Holdings, Inc. expanded orthopedic recovery and spinal fusion support technologies across Europe and North America, strengthening adoption of non-invasive bone stimulation therapies in hospitals and specialty clinics.
October 2025: Bioventus LLC increased investments in ultrasound bone healing technologies across the United States and Europe, supporting faster fracture recovery and improved post-surgical bone regeneration outcomes.
September 2025: Rising collaborations between orthopedic device companies and healthcare providers across Germany, Japan, and China accelerated development of AI integrated and sensor-enabled bone growth stimulation systems.
August 2025: Stryker Corporation and DePuy Synthes strengthened their orthopedic surgery portfolios across North America and Europe through expanded focus on spinal fusion procedures and advanced bone regeneration technologies.
July 2025: Increasing regulatory support and reimbursement expansion for non-invasive bone stimulators across Europe and Asia-Pacific encouraged broader adoption of PEMF and ultrasound-based bone healing therapies.
June 2025: Growing prevalence of osteoporosis, sports injuries, and orthopedic trauma cases across Asia-Pacific and Middle East regions accelerated demand for advanced bone growth stimulators and biologic bone healing solutions globally.
Why Purchase the Report?
- To visualize the global bone growth stimulators market segmentation based on product, application, end-user, and region, as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development
- Excel data sheet with numerous data points of global bone growth stimulators market level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping is available in excel consisting of key products of all the major players.
The global bone growth stimulators market report would provide approximately 62 tables, 63 figures, and 182 Pages.
Target Audience
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
